IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 23 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,336 | – | 1,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 932,200 | $4,792,000 | 0.21% |
| Ikarian Capital, LLC | 77,650 | $399,000 | 0.05% |
| Gradient Capital Advisors, LLC | 20,000 | $103,000 | 0.04% |
| Belvedere Trading LLC | 37,100 | $209,000 | 0.01% |
| WEST PACES ADVISORS INC. | 1,665 | $8,558 | 0.00% |
| OSAIC HOLDINGS, INC. | 20 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,113 | $67,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 57,517 | $295,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,466 | $18,000 | 0.00% |